S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
NASDAQ:ISO

IsoPlexis (ISO) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.76
$0.76
50-Day Range
$0.74
$1.13
52-Week Range
$0.60
$5.10
Volume
N/A
Average Volume
68,375 shs
Market Capitalization
$30.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ISO stock logo

About IsoPlexis Stock (NASDAQ:ISO)

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

ISO Stock News Headlines

My next big prediction isn’t a prediction
I believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.
IsoPlexis Corporation
The only AI company you should be looking at
This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.
10-Q: PHENOMEX INC.
PhenomeX Reports First Quarter 2023 Financial Results
PhenomeX Strengthens Commercial Leadership Team
IsoPlexis Reports Preliminary Full Year 2022 Revenue
See More Headlines
Receive ISO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IsoPlexis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:ISO
Fax
N/A
Employees
459
Year Founded
N/A

Profitability

Net Income
$-106,000,000.00
Net Margins
-632.41%
Pretax Margin
-632.40%

Debt

Sales & Book Value

Annual Sales
$16.76 million
Book Value
$1.04 per share

Miscellaneous

Free Float
37,218,000
Market Cap
$30.28 million
Optionable
Not Optionable
Beta
1.32
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Sean Mackay (Age 40)
    Co-Founder, CEO, Pres & Director
    Comp: $635.55k
  • Mr. John R. Strahley CPA (Age 55)
    Chief Financial Officer
    Comp: $444.11k
  • Mr. Rong Fan
    Co-Founder & Chairman of Scientific Advisory Board
  • Mr. Jon Chen
    VP of Scientific Alliance Technology & Co-Founder
  • Mr. Anthony Catalano
    Sr. VP of Operations
  • Mr. Rajesh T. Khakhar
    VP of Fin. & Principal Accounting Officer
  • Ms. Jing Zhou M.D. (Age 52)
    Ph.D., Chief Scientific Officer
  • Mr. Richard W. Rew II (Age 54)
    Sr. VP, Gen. Counsel & Sec.
  • Ms. Verna Siu
    Sr. VP of Sales Operations
  • Ms. Carrie Carter
    Sr. VP of People Operations

ISO Stock Analysis - Frequently Asked Questions

How were IsoPlexis' earnings last quarter?

IsoPlexis Co. (NASDAQ:ISO) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($10.66) earnings per share for the quarter, missing the consensus estimate of ($0.79) by $9.87. The business earned $4.19 million during the quarter, compared to analysts' expectations of $3.79 million. IsoPlexis had a negative trailing twelve-month return on equity of 127.86% and a negative net margin of 632.41%.

When did IsoPlexis IPO?

(ISO) raised $125 million in an initial public offering on Friday, October 8th 2021. The company issued 8,333,000 shares at a price of $14.00-$16.00 per share.

This page (NASDAQ:ISO) was last updated on 3/19/2024 by MarketBeat.com Staff

From Our Partners